Dr. Kriti Mittal, MD, MS
Claim this profileUMass Memorial Medical Center - University Campus
Studies Cancer
Studies Prostate Cancer
7 reported clinical trials
19 drugs studied
Affiliated Hospitals
Clinical Trials Kriti Mittal, MD, MS is currently running
Radium-223 + Cabozantinib
for Kidney Cancer with Bone Metastasis
This phase II trial studies whether adding radium-223 dichloride to the usual treatment, cabozantinib, improves outcomes in patients with renal cell cancer that has spread to the bone. Radioactive drugs such as radium-223 dichloride may directly target radiation to cancer cells and minimize harm to normal cells. Cabozantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving radium-223 dichloride and cabozantinib may help lessen the pain and symptoms from renal cell cancer that has spread to the bone, compared to cabozantinib alone.
Recruiting1 award Phase 216 criteria
Radium-223 + Docetaxel
for Prostate Cancer
The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. Earlier studies helped show that the combination is safe, but the combination has not been proven to work better than either drug alone. The goal of this study is to find out if combining docetaxel and radium-223 is better than giving either drug by itself.
Recruiting2 awards Phase 323 criteria
More about Kriti Mittal, MD, MS
Clinical Trial Related4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Kriti Mittal, MD, MS has experience with
- Antiandrogen Therapy
- Radium-223
- Docetaxel
- Radium-223 Dichloride
- Cabozantinib
- Abiraterone Acetate
Breakdown of trials Kriti Mittal, MD, MS has run
Cancer
Prostate Cancer
Urothelial Carcinoma
Allergy
Renal Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kriti Mittal, MD, MS specialize in?
Kriti Mittal, MD, MS focuses on Cancer and Prostate Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Kriti Mittal, MD, MS currently recruiting for clinical trials?
Yes, Kriti Mittal, MD, MS is currently recruiting for 3 clinical trials in Worcester Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Kriti Mittal, MD, MS has studied deeply?
Yes, Kriti Mittal, MD, MS has studied treatments such as Antiandrogen Therapy, Radium-223, Docetaxel.
What is the best way to schedule an appointment with Kriti Mittal, MD, MS?
Apply for one of the trials that Kriti Mittal, MD, MS is conducting.
What is the office address of Kriti Mittal, MD, MS?
The office of Kriti Mittal, MD, MS is located at: UMass Memorial Medical Center - University Campus, Worcester, Massachusetts 01655 United States. This is the address for their practice at the UMass Memorial Medical Center - University Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.